IQB-782 is a cysteine derivative with potent expectorant activity; it inhibits thrombin-activatable fibrinolysis inhibitor (TAFI) with an Ki(app) of 0.14 μM; it also inhibits TAFI-related carboxypeptidases, showing IC50 values of 49 μM and 12 μM for CPN and CPB, respectively.